Gastric cancer is associated with NOS2 -954G/C polymorphism and environmental factors in a Brazilian population

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Jorge, Yvana C ^a   Duarte, Marcia C ^a   Silva, Ana E ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; LEUCINE; SERINE; NOS2A PROTEIN, HUMAN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BRAZIL; CANCER RISK; CHRONIC GASTRITIS; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; STOMACH CANCER; STOMACH CARCINOGENESIS; ADENOCARCINOMA; CASE CONTROL STUDY; DRINKING BEHAVIOR; ENVIRONMENTAL HEALTH; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SMOKING; STATISTICAL MODEL; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BRAZIL; CASE-CONTROL STUDIES; ENVIRONMENTAL HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HELICOBACTER INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE II; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; STOMACH NEOPLASMS;

EID: 77953556998     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-64     Document Type: Article

References (46)

1. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol 2009, 472:467-477. full_text, 19107449.
2. Boccia S, Sayed-Tabatabaei F, Persiani R, Gianfagna F, Rausei S, Arzani D, La Greca A, D'Ugo D, La Torre G, van Duijn C, Ricciardi M. Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population. BMC Cancer 2007, 7:1-8. 10.1186/1471-2407-7-206, 1769389, 17199887.
3. INCA - National Institute of Cancer: Incidence and mortality ratios by cancer in Brazil. , http://www2.inca.gov.br/wps/wcm/connect/inca/portal/home
4. Huang J, Zheng J, Sumanac K, Irvine J, Hunt RH. Meta-Analysis of the Relationship Between cagA Seropositivity and Gastric Cancer. Gastroenterology 2003, 125:1636-1644. 10.1053/j.gastro.2003.08.033, 14724815.
5. Kandulski A, Selgrad M, Malfertheiner P. Helicobacter pylori infection: A clinical overview. Digest Liver Dis 2008, 40:619-626.
6. Robbins T, Cotran RS. Stomach. Pathologic bases of diseases 2005, 787-801. Philadelphia: Saunders, 6.
7. Correa P. Human model of gastric carcinogenesis. CancerRes 1988, 48:3554-3560.
8. Hamajima N, Naito M, Kondo T, Goto Y. Genetic factors involved in the development of Helicobacter pylori-related gastric cancer. Cancer Sci 2006, 97:1129-38. 10.1111/j.1349-7006.2006.00290.x, 16879717.
9. Augusto AC, Miguel F, Mendonça S, Pedrazzoli J, Gurgueira SS. Oxidative stress expression status associated to Helicobacter pylori virulence in gastric diseases. Clin Biochem 2007, 40:615-622. 10.1016/j.clinbiochem.2007.03.014, 17466292.
10. Jaiswal M, Larusso NF, Nishioka N, Nakabeppu Y, Gores GJ. Human Ogg 1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide. Cancer Res 2001, 61:6388-6393.
11. Liew FY, Li Y, Millott S. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major trough the induction of nitric oxide. J Immunol 1990, 145:4306-4043.
12. Yu J, Guo F, Ebert MPA, Malfertheiner P. Expression of inducible nitric oxide synthase in human gastric cancer. World J Gastroenterol 1999, 5:430-431.
13. Cooper RG, Magwere T. Nitric oxide-mediated pathogenesis during nicotine and alcohol consumption. Indian J Physiol Pharmacol 2008, 52:11-18.
14. Pepine CJ. The Impact of Nitric Oxide in Cardiovascular Medicine: Untapped Potential Utility. Am J Med 2009, 122:S10-S15. 10.1016/j.amjmed.2009.03.003, 19393821.
15. Sawa T, Ohshima H. Nitrative DNA damage in inflammation and its possible role in carcinogenesis. Nitric Oxide 2006, 14:91-100. 10.1016/j.niox.2005.06.005, 16099698.
16. Marrogi AJ, Travis WD, Welsh JA, Khan MA, Rahim H, Tazelaar H, Pairolero P, Trastek V, Jett J, Caporaso NE, Liotta LA, Harris CC. Nitric oxide synthase, cycloxygenase 2 and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin Cancer Res 2000, 6:4739-4744.
17. Shen J, Wang RT, Wang LW, Xu YC, Wang XR. A novel genetic polymorphism of inducible nitric oxide synthase is associated with an increased risk of gastric cancer. World J Gastroenterol 2004, 10:3278-3283.
18. Levesque MC, Hobbs MR, Aantsey NM, Vaugh TN, Chancellor JA, Pole A, Perkins DJ, Misukonis MA, Chanoc SJ, Granger DL, Weiberg B. Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production and disease severity in Tanzanian children with malaria. J Infect Dis 1999, 180:1994-2002. 10.1086/315140, 10558957.
19. Kun JF, Mordmuller B, Perkins DJ, May J, Mercereau-Puijalon O, Alpers M, Weinberg JB, Kremsner PG. Nitric Oxide Synthase 2Lambaréné (G-954C), increased nitric oxide production, and protection against malaria. J Infect Dis 2001, 184:330-336. 10.1086/322037, 11443559.
20. Hobbs MR, Udhayakumar V, Levesque MC, Booth J, Roberts JM, Tkachuk AN, Pole A, Coon H, Kariuki S, Nahlen BL, Mwaikambo ED, Lal EL, Granger DL, Anstey NM, Weinberg JB. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet 2002, 360:1468-1475. 10.1016/S0140-6736(02)11474-7, 12433515.
21. Burgner D, Usen S, Rocket K, Jallow M, Ackerman H, Cervino A, Pinder H, Kwiatkowski DP. Nucleotide and haplotic diversity of the NOS2A promoter region and its relationship to cerebral malaria. Hum Genet 2003, 112:379-386.
22. Burgner D, Usen S, Rocket K, Ackerman H, Hull J, Pinder M, Kwiatkowski DP. Haplotypic relationship between SNP and microsatellite markers at the NOS2A locus in two populations. Genes and Imunity 2003, 4:506-514.
23. Cramer JP, Mockenhaupt FP, Ehrhardt S, Burkhardt S, Otchwemah RN, Dietz E, Gellert S, Bienzle U. iNOS promoter variants and severe malaria in Ghanaian children. Trop Med Int Health 2004, 9:1074-1080. 10.1111/j.1365-3156.2004.01312.x, 15482399.
24. Mearin F, García-Gonzalez M, Strunk M, Zárate N, Malagelada J, Lanas A. Association Between Achalasia and Nitric Oxide Synthase Gene Polymorphisms. Am J Gastroenterol 2006, 101:1979-1984. 10.1111/j.1572-0241.2006.00762.x, 16848803.
25. Ferguson HR, Wild CP, Anderson LA, Murphy SJ, Johnston BT, Murray LJ, Watson P, McGuigan J, Reynolds JV, Hardie LJ. Cyclooxygenase-2 and Inducible Nitric Oxide Synthase Gene Polymorphisms and Risk of Reflux Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2008, 17:727-31. 10.1158/1055-9965.EPI-07-2570, 18349295.
26. Lee K, Kang D, Park SK, Berndt SI, Reding D, Chatterjee N, Chanock S, Huang W, Hayes RB. Nitric oxide synthase gene polymorphisms and prostate cancer risk. Carcinogenesis 2009, 30:621-625. 10.1093/carcin/bgp028, 2664454, 19168583.
27. Asensi V, Montes AH, Valle E, Ocãna MG, Astudillo A, Alvarez V, Lopes-Anglada E, Solís A, Coto E, Meana A, Gonzalez P, Carton JA, Paz J, Fierer J, Celada A. The NOS3 (27-bp repeat, intron 4) polymorphism is associated susceptibility to osteomyelitis. Nitric Oxide 2007, 16:44-53. 10.1016/j.niox.2006.06.005, 16889995.
28. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002, 420:860-867. 10.1038/nature01322, 2803035, 12490959.
29. Berasain C, Castillo J, Perugorria MJ, Latasa MU, Prieto J, Ávila MA. Inflammation and Liver Cancer: New Molecular Links. Ann NY Acad Sci 2009, 1155:206-221. 10.1111/j.1749-6632.2009.03704.x, 19250206.
30. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: The updated Sydney System. Am J Surg Pathol 1996, 20:1161-1181. 10.1097/00000478-199610000-00001, 8827022.
31. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1964, 64:31-49.
32. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 1988, 16:1225. 10.1093/nar/16.3.1225, 334774, 2894010.
33. Holla LI, Stejskalova A, Znojil V, Vasku A. Analysis of the inducible nitric oxide synthase gene polymorphisms in Czech patients with atopic diseases. Clin Exp Allergy 2006, 36:1592-1601. 10.1111/j.1365-2222.2006.02612.x, 17177683.
34. Morris JB, Markus MA, Glenn CL, Adams DJ, Colagiuri S, Wang XL. Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes. J Mol Med 2002, 80:96-104. 10.1007/s00109-001-0287-1, 11907646.
35. Gonzalez-Gay MA, Llorca JA, Sanchez E, Lopez-Nevot MA, Amoli MM, Garcia-Porrua C, Ollier WER, Martin J. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain. Rheumatology 2004, 43:1182-1185. 10.1093/rheumatology/keh283, 15226517.
36. Canzian F, Francechi S, Plummer M, van Doorn L, Lu Y, Gioia-Patricola L, Vivas J, Lopez G, Severson RK, Schwartz AG, Munõz N, Kato I. Genetic polymorphisms in mediators of inflammation and gastric precancerous lesions. Eur J Cancer Prev 2008, 17:178-183. 10.1097/CEJ.0b013e3282b6fd88, 18287876.
37. Johannsen J, Pie A, Paiot F, Kristiansen OP, Karlsen AE, Nerup J. Linkage of the human inducible nitric oxide synthase gene to type I diabetes. J Clin Endocrinol Metab 2001, 86:2792-2796. 10.1210/jc.86.6.2792, 11397889.
38. Deng X, Deitrich RA. Ethanol Metabolism and Effects: Nitric Oxide and its Interaction. Curr Clin Pharmacol 2007, 2:145-153. 10.2174/157488407780598135, 2562584, 18690862.
39. Jelski W, Szmitkowski M. Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) in the cancer diseases. Clin Chim Acta 2008, 395:1-5. 10.1016/j.cca.2008.05.001, 18505683.
40. Shin V, Wu W, Chu K, Wong H, Lam E, Tai E, Koo M, Cho C. Nicotine Induces Cyclooxygenase-2 and Vascular Endothelial Growth Factor Receptor-2 in Association with Tumor-Associated Invasion and Angiogenesis in Gastric Cancer. Mol Cancer Res 2005, 3:607-615. 10.1158/1541-7786.MCR-05-0106, 16317086.
41. Boutlis CCS, Hobbs MR, Marsh RL, Misukonis MA, Tkachuk AN, Lagog M, Booth J, Granger DL, Bockarie MJ, Mgone CS, Levesque MC, Weinberg JB, Antsey NM. Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: Relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population. Am J Trop Med Hyg 2003, 6:569-573.
42. Kun JF, Mordmuller B, Lell B, Lehman LG, Luckner D, Kremsner PG. Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 1998, 351:265-266. 10.1016/S0140-6736(05)78273-8, 9457101.
43. Fránsen K, Elander N, Soderkvist P. Nitric oxide synthase 2 (NOS2) promoter polymorphisms in colorectal cancer. Cancer Letters 2005, 225:99-103. 10.1016/j.canlet.2005.02.006, 15922861.
44. Ladeira MSP, Salvadori DMF, Rodrigues MAM. Biopathology of Helicobacter pylori. J Bras Patol Med Lab 2002, 39:335-342.
45. Salzano FM, Freire-Maia N. The origins. Problems in human biology: a study of Brazilian populations 1970, Detroit: Wayne State University Press, 1.
46. Gonçalves VF, Carvalho CMB, Bortolini MC, Bydlowski SP, Pena SDJ. The Phylogeography of African Brazilians. Hum Hered 2008, 65:23-32. 10.1159/000106059, 17652961.